42
Participants
Start Date
April 30, 2008
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
PF-04603629
Subjects will be given either PF-04603629 or Placebo in a blinded fashion. Subjects will receive 4 weekly injections of PF-04603629 or Placebo.
Placebo
Subjects will be given either PF-04603629 or Placebo in a blinded fashion during the study. Subjects will receive 4 weekly injections of PF-04603629 or Placebo.
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Portland
Lead Sponsor
Pfizer
INDUSTRY